Grau-Rivera, O., Navalpotro-Gomez, I., Sánchez-Benavides, G., Suárez-Calvet, M., Milà-Alomà, M., Arenaza-Urquijo, E. M., . . . Study, f. t. A. (2021). Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease. Alzheimer's Research & Therapy, 13(1), 1. https://doi.org/10.1186/s13195-021-00781-z
Chicago Style (17th ed.) CitationGrau-Rivera, Oriol, et al. "Association of Weight Change with Cerebrospinal Fluid Biomarkers and Amyloid Positron Emission Tomography in Preclinical Alzheimer's Disease." Alzheimer's Research & Therapy 13, no. 1 (2021): 1. https://doi.org/10.1186/s13195-021-00781-z.
MLA (9th ed.) CitationGrau-Rivera, Oriol, et al. "Association of Weight Change with Cerebrospinal Fluid Biomarkers and Amyloid Positron Emission Tomography in Preclinical Alzheimer's Disease." Alzheimer's Research & Therapy, vol. 13, no. 1, 2021, p. 1, https://doi.org/10.1186/s13195-021-00781-z.